PetVivo receives final $600K installment of $1M equity financing; issues 1.25M units at $0.80/unit

PetVivo Holdings, Inc.

Received $600K on April 15, 2026 as final payment under March 13 Subscription Agreement, completing $1M total investment.
Issued 1,250,000 units at $0.80/unit; each unit = one share common + one warrant (exercise $1.10, expires 3 years).
Of total, 750,000 units issued upon $600K final installment.
Investor has option to buy up to $1.5M additional units (max 1,875,000 units) on same terms by June 15, 2026.
Proceeds to fund commercialization of lead product Spryng™, new product development, clinical trials, and working capital.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.